BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

693 related articles for article (PubMed ID: 8196769)

  • 1. Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.
    Leevers SJ; Paterson HF; Marshall CJ
    Nature; 1994 Jun; 369(6479):411-4. PubMed ID: 8196769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions between Ras and Raf: key regulatory proteins in cellular transformation.
    Marshall M
    Mol Reprod Dev; 1995 Dec; 42(4):493-9. PubMed ID: 8607981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different structural requirements within the switch II region of the Ras protein for interactions with specific downstream targets.
    Moodie SA; Paris M; Villafranca E; Kirshmeier P; Willumsen BM; Wolfman A
    Oncogene; 1995 Aug; 11(3):447-54. PubMed ID: 7630628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TC21 and Ras share indistinguishable transforming and differentiating activities.
    Graham SM; Oldham SM; Martin CB; Drugan JK; Zohn IE; Campbell S; Der CJ
    Oncogene; 1999 Mar; 18(12):2107-16. PubMed ID: 10321735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor.
    York RD; Yao H; Dillon T; Ellig CL; Eckert SP; McCleskey EW; Stork PJ
    Nature; 1998 Apr; 392(6676):622-6. PubMed ID: 9560161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of insulin on the activation of the Raf/Mos-dependent MAP kinase cascade in vitellogenic versus postvitellogenic Xenopus oocytes.
    Chesnel F; Bonnec G; Tardivel A; Boujard D
    Dev Biol; 1997 Aug; 188(1):122-33. PubMed ID: 9245517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligomerization activates c-Raf-1 through a Ras-dependent mechanism.
    Luo Z; Tzivion G; Belshaw PJ; Vavvas D; Marshall M; Avruch J
    Nature; 1996 Sep; 383(6596):181-5. PubMed ID: 8774885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras controls coupling of growth factor receptors and protein kinase C in the membrane to Raf-1 and B-Raf protein serine kinases in the cytosol.
    Troppmair J; Bruder JT; App H; Cai H; Liptak L; Szeberényi J; Cooper GM; Rapp UR
    Oncogene; 1992 Sep; 7(9):1867-73. PubMed ID: 1386920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-O-octadecyl-2-O-methyl-glycerophosphocholine inhibits the transduction of growth signals via the MAPK cascade in cultured MCF-7 cells.
    Zhou X; Lu X; Richard C; Xiong W; Litchfield DW; Bittman R; Arthur G
    J Clin Invest; 1996 Aug; 98(4):937-44. PubMed ID: 8770865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
    Arai H; Escobedo JA
    Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Ras displaces 14-3-3 protein from the amino terminus of c-Raf-1.
    Rommel C; Radziwill G; Lovrić J; Noeldeke J; Heinicke T; Jones D; Aitken A; Moelling K
    Oncogene; 1996 Feb; 12(3):609-19. PubMed ID: 8637718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid activation of mitogen-activated protein kinase and p21ras by prolactin and interleukin 2 in rat Nb2 node lymphoma cells.
    Rao YP; Buckley DJ; Buckley AR
    Cell Growth Differ; 1995 Oct; 6(10):1235-44. PubMed ID: 8845300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic activation of c-fos promoter activity by Raf and Ral GDP dissociation stimulator.
    Okazaki M; Kishida S; Hinoi T; Hasegawa T; Tamada M; Kataoka T; Kikuchi A
    Oncogene; 1997 Feb; 14(5):515-21. PubMed ID: 9053849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1.
    Zhang XF; Settleman J; Kyriakis JM; Takeuchi-Suzuki E; Elledge SJ; Marshall MS; Bruder JT; Rapp UR; Avruch J
    Nature; 1993 Jul; 364(6435):308-13. PubMed ID: 8332187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the sites of interaction between c-Raf-1 and Ras-GTP.
    Barnard D; Diaz B; Hettich L; Chuang E; Zhang XF; Avruch J; Marshall M
    Oncogene; 1995 Apr; 10(7):1283-90. PubMed ID: 7731678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth.
    Ehrhardt GR; Korherr C; Wieler JS; Knaus M; Schrader JW
    Oncogene; 2001 Jan; 20(2):188-97. PubMed ID: 11313946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells.
    Sakoda T; Kaibuchi K; Kishi K; Kishida S; Doi K; Hoshino M; Hattori S; Takai Y
    Oncogene; 1992 Sep; 7(9):1705-11. PubMed ID: 1323817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation.
    Rey I; Taylor-Harris P; van Erp H; Hall A
    Oncogene; 1994 Mar; 9(3):685-92. PubMed ID: 8108110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Raf as a result of recruitment to the plasma membrane.
    Stokoe D; Macdonald SG; Cadwallader K; Symons M; Hancock JF
    Science; 1994 Jun; 264(5164):1463-7. PubMed ID: 7811320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.